Related Experiment Videos

Medicare billing: ignorance is not a defense

Advance for Nurse Practitioners

|June 5, 1998

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

ESMO open·2021

Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.

ESMO open·2021

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.

ESMO open·2021

See all related articles